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Abstract: Introduction: Many studies in stem cell biology have demonstrated that dental pulp stem
cells (DPSC) may be highly proliferative and capable of pluripotent differentiation into many different
tissue types. Recent advances in stem cell research have outlined methods for directing in vitro
or in vivo growth, viability, and proliferation, as well as differentiation of DPSC—although much
remains to be discovered. Based upon this information, the primary objective of this study was to
understand the functional biomaterials needed to more effectively direct DPSC viability, growth, and
proliferation. Methods: Using an approved protocol, previously collected and isolated samples of
DPSC from an existing repository were used. Previously established stem cell biomarkers (Sox-2,
Oct-4, NANOG) from each isolate were correlated with their proliferation rates or doubling times
to categorize them into rapid, intermediate, or slow-dividing multipotent DPSC. Growth factors
and other functional dental biomaterials were subsequently tested to evaluate DPSC responses
in proliferation, viability, and morphology. Results: Differential responses were observed among
DPSC isolates to growth factors, including vascular endothelial growth factor (VEGF) and bone
morphogenic protein (BMP-2), and functional biomaterials such as mineralized trioxide aggregates
(MTA). The responsiveness of DPSC isolates did not correlate with any single factor but rather with
a combination of proliferation rate and biomarker expression. Conclusions: These data strongly
suggest that some, but not all, DPSC isolates are capable of a robust and significant in vitro response
to differentiation stimuli, although this response is not universal. Although some biomarkers and
phenotypes that distinguish and characterize these DPSC isolates may facilitate the ability to predict
growth, viability, and differentiation potential, more research is needed to determine the other
intrinsic and extrinsic factors that may contribute to and modulate these DPSC responses to these
functional biomaterials for biotechnology and bioengineering applications.
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Many studies in stem cell biology have demonstrated that dental pulp stem cells
(DPSC) may be highly proliferative and capable of pluripotent differentiation into many
different tissue types [1,2]. For example, evidence has shown that DPSC may be induced
into dentinogenesis, osteogenesis, chondrogenesis, adipogenesis, and neurogenesis [3,4].
However, much remains to be discovered regarding the materials and methods used to
stimulate growth, increase viability, and promote differentiation, as well as the biomarkers
and properties of the DPSC that determine their differentiation potential [5–7].
Recent advances in stem cell research have outlined the characteristics of DPSC that
may be useful in directing in vitro or in vivo differentiation [8,9]. For example, stem cells
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from human exfoliated deciduous teeth (SHED) and stem cells from the apical papilla
(SCAP) may express vastly different biomarkers and differentiation potentials [10,11]. Moreover, the methods used to isolate and store these DPSC may also influence the capacity and
potential of these DPSC isolates for any therapeutic or bioengineering purposes [12,13].
For example, some studies have revealed that the isolation of DPSC using enzymatic
dissociation may result in heterogenous DPSC isolate populations of more rapidly dividing
cells, while the direct outgrowth technique from tissue explants may be more likely to
give rise to more homogenous isolates with more limited differentiation potential [14,15].
In addition to the isolation methods used, the protocols and techniques used in cryopreservation may also influence the potential viability and long-term survival following
cryopreservation—with research studies suggesting that both lower passage number and
decreased concentration of dimethyl sulfoxide (DMSO) may significantly improve both
survival and viability outcomes among DPSC isolates [13,15].
Other research has outlined potential methods used to direct in vitro or in vivo differentiation [16,17]. Some of these efforts have involved the use of defined growth factors
and growth media supplements, including the use of transforming growth factor (TGF),
platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and nerve growth
factor (NGF) to induce DPSC differentiation [18–20]. However, the most commonly cited
and effective growth factors added to cell culture media that appear to modulate differentiation across many types of DPSC include bone morphogenic protein (BMP) and vascular
endothelial growth factor (VEGF)—which have been demonstrated to increase proliferation
as well as viability in these studies [16–20]. Other researchers have explored the potential
bioactivity of dental materials, such as endodontic biomaterials including mineralized
trioxide aggregates (MTA) on DPSC [21–23]. However, the vast majority of these studies
to date have not included an extensive characterization of these DPSC isolates, including
proliferation rate or doubling time, biomarker expression, and analysis of pluripotent
differentiation markers—which may, in fact, be critical to understanding which factors may
modulate specific responses among differing DPSC isolates to induce differentiation.
Based upon this information, the primary objective of this study was to understand the
biology and biotechnology needed to more effectively modulate DPSC phenotypes, including growth, viability, and proliferation, using BMP, VEGF, and MTA on well-characterized
DPSC isolates.
2. Methods
2.1. Study Approval
Previously collected and isolated samples of DPSC from an existing repository were
used. Due to the use of previously collected, non-identifiable samples, this protocol
was granted exemption from Human Subjects review from the University of Nevada,
Las Vegas (UNLV) Office for the Protection of Research Subjects (OPRS) #763012-1 titled
“Retrospective analysis of dental pulp stem cells (DPSC) from the University of Nevada,
Las Vegas (UNLV) School of Dental Medicine (SDM) pediatric and clinical population” on
3 August 2015.
The original protocol for the collection and storage of DPSC was reviewed and approved by the Institutional Review Board (IRB) and UNLV OPRS under OPRS#0907-3148
“Isolation of Non-Embryonic Stem Cells from Dental Pulp” [24] on 5 February 2010.
2.2. Cell Culture
DPSC isolates frozen in 10% dimethyl sulfoxide (DMSO)-containing media were
thawed and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) High Glucose with
the addition of 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin streptomycin (Pen-Strep) at 37 ◦ C in a humidified tissue culture incubator with 5% CO2 . DMSO
(CAS 67-68-5), DMEM (MT15017CV), FBS (MT35011CV), and Pen-Strep (MT30001Cl) were
obtained from Fisher Scientific (Fair Lawn, NJ, USA). Cells were passaged 1:2 and doubling
time was noted for each DPSC isolate. Cell cultures achieving confluence within 1–2 days
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were categorized as rapid doubling time or rDT between 1 and 2 days, with intermediate doubling time or iDT noted between 5 and 6 days, and slow doubling time or sDT
categorized as 10–12 days.
2.3. RNA Isolation
RNA was isolated from each DPSC using the ABgene Total RNA isolation reagent kit
and protocol recommended by ThermoFisher (Fisher Scientific; Fair Lawn, NJ, USA), as
previously described [24,25]. All samples were screened for purity using the NanoDrop
spectrophotometer (Fisher Scientific; Fair Lawn, NJ, USA) absorbance readings at A260
and A280 nm. The ratio of A260:A280 provides an approximation of nucleic acid purity.
All samples were required to demonstrate an A260:A280 ratio above 1.65, which was
suitable for polymerase chain reaction (PCR) screening. Quantification of RNA samples
was concomitantly collected to determine the minimal PCR processing requirement of
1 ng/µL.
2.4. PCR Screening
RNA obtained from each DPSC isolate was subsequently screened for the presence
of CD90 and CD105 and the absence of CD45, according to the International Society for
Cellular Therapy (ISCT) criteria for stem cells [26] using RT-PCR on 1 ug of total RNA
with the ABgene Reverse-iT One-Step RT-PCR kit (ThermoFisher Scientific; Fair Lawn, NJ)
and a Mastercycler gradient thermocycler (Eppendorf; Hamburg, Germany) that included
an initial reverse transcription at 47 ◦ C for 30 min, followed by 30, cycles of PCR with
annealing for 30 sec at the appropriate temperature for each primer set, and final extension
at 60 ◦ C for one minute, as previously described [24–26]. The PCR positive cellular RNA
control was glyceraldehyde 3-phosphate dehydrogenase (GAPDH). In addition, three
additional mesenchymal stem cell (MSC) markers (Sox-2, Oct-4, and NANOG) were also
used with the following primers, synthesized by SeqWright (Fisher Scientific; Fair Lawn,
NJ, USA).
CD90 forward: 50 -ATGAACCTGGCCATCAGCA-30 ; 19 nt, 53% GC, Tm: 67 ◦ C
CD90 reverse: 50 -GTGTGCTCAGGCACCCC-30 ; 17 nt, 71% GC, Tm: 70 ◦ C
Optimal Tm: 68 ◦ C
CD105 forward: 50 -CCACTAGCCAGGTCTCGAAG-30 ; 20 nt, 60% GC, Tm: 67 ◦ C
CD105 reverse: 50 -GATGCAGGAAGACACTGCTG-30 ; 20 nt, 55% GC, Tm: 66 ◦ C
Optimal Tm: 67 ◦ C
CD45 forward: 50 CATATTTATTTTGTCCTTCTCCCA-30 ; 24 nt, 33% GC, Tm: 60 ◦ C
CD45 reverse: 50 -GAAAGTTTCCACGAACGG-30 ; 18 nt, 50% GC, Tm: 61 ◦ C
Optimal Tm: 61 ◦ C
Oct-4 forward: 50 -TGGAGAAGGAGAAGCTGGAGCAAAA-30 ; 25 nt: 48% GC; Tm
◦
70 C Oct4 reverse: 50 -GGCAGATGGTCGTTTGGCTGAATA-30 ; 24 nt; 50% GC; Tm 70 ◦ C
Optimal Tm: 71 ◦ C
Sox2 forward: 50 -ATGGGCTCTGTGGTCAAGTC-30 ; 20 nt: 55% GC; Tm 67 ◦ C
Sox2 reverse: 50 -CCCTCCCAATTCCCTTGTAT-50 ; 20 nt; 50% GC; Tm 64 ◦ C
Optimal Tm: 65 ◦ C
NANOG forward: 50 -GCTGAGATGCCTCACACGGAG-30 ; 21 nt; 62% GC; Tm 71 ◦ C
NANOG reverse: 50 -TCTGTTTCTTGACTGGGACCTTGTC-30 ; 25 nt: 48%GC; Tm
◦
69 C Optimal Tm: 70 ◦ C
GAPDH forward: 50 ATCTTCCAGGAGCGAGATCC-30 ; 20 nt, 55% GC, Tm 66 ◦ C
GAPDH reverse: 50 ACCACTGACACGTTGGCAGT-30 ; 20 nt, 55% GC, Tm 70 ◦ C
Optimal Tm: 61 ◦ C
2.5. Proliferation Assays
DPSC isolates were plated in sterile, tissue culture-treated Corning Costar 96-well
assay plates (Fisher Scientific 07-200-90; Fair Lawn, NJ, USA) at a concentration of 1.2 × 104
cells/mL for three days. Experimental wells were treated with either 10 ng/mL of Gibco
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with recombinant vascular endothelial growth factor (VEGF, ThermoFisher #PHC9393;
Fair Lawn, NJ, USA) or bone morphogenic protein (BMP-2, ThermoFisher #PHC7141;
Fair Lawn, NJ, USA) or plated with 10 ug of MTA (Henry Schein #7040069; Melville, NY,
USA). Plates were subsequently fixed with 10% neutral buffered formalin (ThermoScientific
22-045-400; Fair Lawn, NJ, USA) and stained using Gentian Violet 1% aqueous solution
(Ricca Chemical 7647-01-0 from Fisher Scientific; Fair Lawn, NJ, USA). Absorbance was
read using an ELx808 BioTek microplate reader (BioTek; Winooski, VT, USA) at 595 nm to
calculate cellular proliferation and for comparison with negative controls.
2.6. Viability Assays
Cellular viability was determined using the Trypan Blue exclusion assay from Gibco
(Fisher Scientific #15250061; Fair Lawn, NJ, USA). Cells (experimental, control) were
processed using a BioRad TC20 automated cell counter (BioRad; Hercules, CA, USA) to
determine the absolute and relative percentage of viable cells. Cell densities were also
calculated for both experimental and negative controls.
2.7. Experimental Factors
Growth factors were obtained from Fisher Scientific, which included vascular endothelial growth factor (VEGF; catalog PHC9393) and bone morphogenic protein (BMP;
catalog PHC7141). Experimental wells were treated with growth factor (VEGF or BMP-2)
at physiologically relevant concentrations approximating 10 ng/mL—within the range of
other studies of DPSC responsiveness to these growth factors [27–30]. Mineralized trioxide
aggregate (MTA) was obtained from Henry Schein (catalog 7040069). In brief, MTA was
mixed separately under sterile conditions in a BSL-2 biosafety cabinet according to the
manufacturer instructions and 10 µL was transferred into each experimental well of a
96-well assay plate prior to cell plating (as described above).
2.8. Statistical Analysis
All parametric analyses of growth and viability were exported to Microsoft Excel (XLS)
and subsequently analyzed using two-tailed t-tests. Statistical differences were calculated
using an alpha level of 0.05 for statistical significance, as previously described [30,31].
Differences in RNA concentration were calculated based upon the doubling time (DT) or
group, which are non-parametric or categorical groups, as previously described [28–32].
These data were analyzed using the Chi square test. Associations were estimated between
growth or viability responsiveness (change) and DPSC categorical variables (rDT, iDT, sDT)
using Pearson’s correlation coefficient or R2 , as previously described [24–26,31,32].
3. Results
Existing DPSC isolates were thawed and placed into culture with the average doubling
time (DT) noted for each (Figure 1). These data demonstrated that two DPSC isolates exhibited a rapid and consistent doubling time or rDT of approximately two days (dpsc-3882,
dpsc-5653). In addition, two DPSC isolates were identified as exhibiting an intermediate
doubling time or iDT of approximately five to six days (dpsc-8124, dpsc-9894). Finally, two
DPSC isolated were found to have slow doubling times or sDT between ten to twelve days
(dpsc-11418, dpsc-11750). The average doubling times for each grouping (rDT, iDT, and
sDT) were significantly different from each other, p = 0.0001.
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Figure 2. Results of DPSC isolate PCR biomarker screening. Positive results for CD90 and CD105 RNA expression were
observed among all DPSC isolates, with negative results for CD45 expression. Differential results were observed among
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R2 = 0.667 and R2 = 0.588, respectively. Finally, the correlations between MTA and DPSC
the responsiveness in viability
and growth of the DPSC isolates by category to BMP-2 was
responsiveness were R2 = 0.904, R2 = 0.831.
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Table 2. Responsiveness of DPSC isolates to stimulus.
DPSC Isolate

VEGF
(Viability, Growth)

BMP-2
(Viability, Growth)

MTA
(Viability, Growth)

dpsc-3882
dpsc-5653
dpsc-8124
dpsc-9894
dpsc-11418
dpsc-11750
rDT
iDT
sDT
Correlation (R2 )

22.1%, 34.2%
26.3%, 32.1%
13.2%, 7.6%
12.4%, 9.9%
2.4%, 1.6%
1.9%, 2.1%
++, +++
++, +
+, +
R2 = 0.868, R2 = 0.82

1.2%, 2.4%
2.2%, 3.1%
3.5%, 2.2%
2.6%, 3.4%
31.6%, 29.1%
25.6%, 19.8%
+, +
+, +
++, ++
R2 = 0.667, R2 = 0.588

−15.2%, −13.9%
−9.1%, −18.4%
−2.5%, −4.2%
−1.3%, −6.1%
23.7%, 17.5%
28.3%, 36.2%
−−, −−
−, −
++, ++
R2 = 0.904, R2 = 0.831

4. Discussion
The primary objective of this study was to understand the biology and biotechnology
needed to more effectively modulate DPSC responsiveness and phenotypes, using BMP,
VEGF, and MTA. The results of this study have demonstrated that specific biological
determinants of DPSC pluripotency, including Sox-2, Oct-4, and NANOG, may be effective
biomarkers to determine the responsiveness of DPSC isolates to various stimuli—at least
in vitro [31,32]. These results support other studies of DPSC characteristics and biomarkers
that evaluate the potential for reprogramming and differentiation [33,34].
In addition, these data also confirm previous studies of DPSC responsiveness to
various growth factors, including VEGF and BMP-2 [18–20,35,36]. One of these previous
studies evaluated the pluripotency transcription factors Sox-2 and Klf-4, but did not
evaluate the potential responsiveness of DPSC isolates to any stimulus or growth factors
based upon expression of these markers [33]. However, this study may be among the first
to demonstrate the differential responsiveness of DPSC to these growth factors based upon
the combination of these specific pluripotency biomarkers (Sox-2, Oct-4, NANOG) and
growth characteristics, such as doubling time or proliferation.
Studies from other groups have identified similar biomarkers among DPSC that may
be used to determine functional differentiation capabilities, such as the expression of Oct-4,
Sox-2, and Klf-4 with Lin28, which may determine DPSC isolates capable of odontoblastic
differentiation [37]. Other research groups have focused on the identification of additional
growth factors that may promote specific and directed differentiation of DPSC isolates,
such as basic fibroblast growth factor (bFGF) promotion of DPSC neural differentiation and
fibroblast growth factor (FGF-2) promotion of DPSC odontoblast differentiation [38,39].
Although the results of this study are novel and suggest effective methods for evaluating and selecting differentiation potential among DPSC isolates, there are several limitations
associated with this study that must be considered. For example, any association between
the expression of these biomarkers and DPSC responsiveness may be coincidental and
not causative. The retrospective nature of this study, combined with both financial and
technical barriers that limited the ability of this group to evaluate this possibility through
knockout or silencing RNA, suggest that future studies may need to include methods to
rule out these possibilities.
In addition, this study was limited to a small number of DPSC isolates. Expanding
this study to include more DPSC isolates with variable expression of these pluripotency
biomarkers will provide substantial information that could validate the findings of the
current study. In addition, a more comprehensive evaluation of other potential biomarkers,
such as non-coding microRNA, may provide more specific and targeted methods for
bioengineering and biotechnology applications utilizing DPSC [40–42].
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5. Conclusions
These data suggest that some DPSC isolates (but not all) are capable of a robust and
significant in vitro response to stimuli, although this response is not universal. Although
some biomarkers and phenotypes that distinguish and characterize these DPSC isolates
may facilitate the ability to predict phenotypic responses and changes in growth or viability potential, more research is needed to determine the other intrinsic and extrinsic
factors that may contribute to and modulate these DPSC responses for biotechnology and
bioengineering applications.
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VEGF
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MTA
SHED
SCAP
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Dental pulp stem cell
vascular endothelial growth factor
bone morphogenic protein
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stem cells from human exfoliated deciduous teeth
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Office for the Protection of Research Subjects
School of Dental Medicine
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FGF

intermediate doubling time
slow doubling time
polymerase chain reaction
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mesenchymal stem cell
glyceraldehyde 3-phosphate dehydrogenase
basic fibroblast growth factor
fibroblast growth factor
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